Literature DB >> 3436346

Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.

L Tax.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436346     DOI: 10.1007/BF03189902

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


× No keyword cloud information.
  15 in total

1.  Testosterone undecanoate: a new orally active androgen.

Authors:  C Hirschhäuser; C R Hopkinson; G Sturm; A Coert
Journal:  Acta Endocrinol (Copenh)       Date:  1975-09

2.  Changes in erectile responsiveness during androgen replacement therapy.

Authors:  J Bancroft; F C Wu
Journal:  Arch Sex Behav       Date:  1983-02

3.  Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

Authors:  N E Skakkebaek; J Bancroft; D W Davidson; P Warner
Journal:  Clin Endocrinol (Oxf)       Date:  1981-01       Impact factor: 3.478

4.  Which testosterone replacement therapy?

Authors:  J A Cantrill; P Dewis; D M Large; M Newman; D C Anderson
Journal:  Clin Endocrinol (Oxf)       Date:  1984-08       Impact factor: 3.478

5.  Mean plasma concentration, metabolic clearance and basal plasma production rates of testosterone in normal young men and women using a constant infusion procedure: effect of time of day and plasma concentration on the metabolic clearance rate of testosterone.

Authors:  A L Southren; G G Gordon; S Tochimoto; G Pinzon; D R Lane; W Stypulkowski
Journal:  J Clin Endocrinol Metab       Date:  1967-05       Impact factor: 5.958

6.  Clinical efficacy of testosterone undecanoate in male hypogonadism.

Authors:  N M Maisey; J Bingham; V Marks; J English; J Chakraborty
Journal:  Clin Endocrinol (Oxf)       Date:  1981-06       Impact factor: 3.478

7.  Bioavailability of oral testosterone in males.

Authors:  H Frey; A Aakvaag; D Saanum; J Falch
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

8.  Plasma androgens after a single oral dose of testosterone undecanoate.

Authors:  G Geere; J Jones; S M Atherden; D B Grant
Journal:  Arch Dis Child       Date:  1980-03       Impact factor: 3.791

9.  Treatment of anorchia with oral testosterone undecanoate: pharmacodynamics and clinical effectiveness.

Authors:  J Weil; F Bidlingmaier; O Butenandt; W G Sippell; W Baumgartner; D Knorr
Journal:  Acta Endocrinol (Copenh)       Date:  1980-10

10.  Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose.

Authors:  R O'Carroll; C Shapiro; J Bancroft
Journal:  Clin Endocrinol (Oxf)       Date:  1985-11       Impact factor: 3.478

View more
  1 in total

1.  Effect of Dose and 5α-Reductase Inhibition on the Circulating Testosterone Metabolite Profile of Men Administered Oral Testosterone.

Authors:  Abdul Basit; John K Amory; Bhagwat Prasad
Journal:  Clin Transl Sci       Date:  2018-06-19       Impact factor: 4.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.